Consistently, THP1- and BMDMs-derived macrophages cocultured with CM from TNFRSF14 knockdown GBM cells showed a decreased ratio of CD163 and CD80 positive cell population compared to the samples treated with CM from control group (Fig. 3G and Figure S3H-J). The gene discussed is CD80; the disease is glioblastoma.